Termination of Registration of a Class of Security Under Section 13 and 15(d) (15-15d)
21 Novembre 2018 - 10:15PM
Edgar (US Regulatory)
|
|
OMB
APPROVAL
|
|
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
OMB
Number:
|
3235-0167
|
|
Expires:
|
May
31, 2021
|
|
Estimated
average burden hours per response
|
1.50
|
FORM
15
CERTIFICATION
AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO
FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
|
Commission File Number
|
333-135434
|
Tian’an
Pharmaceutical Co., Ltd.
(Exact
name of registrant as specified in its charter)
3445 Lawrence Ave., Oceanside, NY 11572
646
768 8417
(Address,
including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Common
and Preferred Shares
(Title
of each class of securities covered by this Form)
(Titles
of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please
place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file
reports:
|
Rule 12g-4(a)(1)
|
☐
|
|
Rule 12g-4(a)(2)
|
☐
|
|
Rule 12h-3(b)(1)(i)
|
☐
|
|
Rule 12h-3(b)(1)(ii)
|
☐
|
|
Rule 15d-6
|
☒
|
|
Rule
15d-22(b)
|
☐
|
Approximate
number of holders of record as of the certification or notice date:
|
2,000
|
|
|
|
Pursuant
to the requirements of the Securities Exchange Act of 1934
(Name of registrant as specified in charter)
has caused this
certification/notice to be signed on its behalf by the undersigned duly authorized person.
Date:
|
11/19/18
|
|
By:
|
/s/ David Lazar
|
Instruction:
This form is required by Rules 12g-4, 12h-3, 15d-6 and 15d-22 of the General Rules and Regulations under the Securities Exchange
Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It
may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person
signing the form shall be typed or printed under the signature.
SEC
2069 (08-11)
|
Persons
who respond to the collection of information contained in this form are not required to respond unless the form displays a
currently valid OMB control number.
|
|
Grafico Azioni Tian An Pharmaceutical (PK) (USOTC:TNPH)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni Tian An Pharmaceutical (PK) (USOTC:TNPH)
Storico
Da Set 2023 a Set 2024
Notizie in Tempo Reale relative a Tian An Pharmaceutical Co Ltd (PK) (OTCMarkets): 0 articoli recenti
Più Tian'an Pharmaceutical Co., Ltd. Articoli Notizie